Accéder au contenu
Merck

Tumor and local lymphoid tissue interaction determines prognosis in high-grade serous ovarian cancer.

Cell reports. Medicine (2023-06-23)
Haonan Lu, Hantao Lou, Georg Wengert, Reema Paudel, Naina Patel, Saral Desai, Bill Crum, Kristofer Linton-Reid, Mitchell Chen, Dongyang Li, Jacey Ip, Francesco Mauri, David J Pinato, Andrea Rockall, Susan J Copley, Sadaf Ghaem-Maghami, Eric O Aboagye
RÉSUMÉ

Tertiary lymphoid structure (TLS) is associated with prognosis in copy-number-driven tumors, including high-grade serous ovarian cancer (HGSOC), although the function of TLS and its interaction with copy-number alterations in HGSOC are not fully understood. In the current study, we confirm that TLS-high HGSOC patients show significantly better progression-free survival (PFS). We show that the presence of TLS in HGSOC tumors is associated with B cell maturation and cytotoxic tumor-specific T cell activation and proliferation. In addition, the copy-number loss of IL15 and CXCL10 may limit TLS formation in HGSOC; a list of genes that may dysregulate TLS function is also proposed. Last, a radiomics-based signature is developed to predict the presence of TLS, which independently predicts PFS in both HGSOC patients and immune checkpoint inhibitor (ICI)-treated non-small cell lung cancer (NSCLC) patients. Overall, we reveal that TLS coordinates intratumoral B cell and T cell response to HGSOC tumor, while the cancer genome evolves to counteract TLS formation and function.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
CD163 (MRQ-26) Mouse Monoclonal Antibody, clone MRQ-26, unconjugated, Cell Marque